Therefore, we read with great interest the recent randomized clinical trial report[1] and Editorial[2] that examined the effect of fluvoxamine on time to recovery in outpatients with mild to moderate COVID-19. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial.